Evidence of Mitochondrial Dysfunction in Autism and Implications for Treatment
暂无分享,去创建一个
[1] M. Lubinsky. Behavioral consequences of congenital rubella. , 1979, The Journal of pediatrics.
[2] Anne-Marie Smith,et al. Plasma Selenium and Plasma and Erythrocyte Glutathione Peroxidase Activity Increase with Estrogen during the Menstrual Cycle , 2003, Journal of the American College of Nutrition.
[3] M. Rice,et al. Enhanced oxidative stress in female rat brain after gonadectomy , 1996, Brain Research.
[4] R. D. Myers,et al. Antagonism by d-amphetamine of trimethyltin-induced hyperactivity: Evidence toward an animal model of hyperkinetic behavior , 1983, Neuropharmacology.
[5] Catarina Correia,et al. Brief Report: High Frequency of Biochemical Markers for Mitochondrial Dysfunction in Autism: No Association with the Mitochondrial Aspartate/Glutamate Carrier SLC25A12 Gene , 2006, Journal of autism and developmental disorders.
[6] J B Poline,et al. Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. , 2000, The American journal of psychiatry.
[7] E. Fombonne,et al. Pervasive developmental disorders in preschool children. , 2001, JAMA.
[8] Nancy J. Minshew,et al. A preliminary 31P MRS study of autism: Evidence for undersynthesis and increased degradation of brain membranes , 1993, Biological Psychiatry.
[9] S. Philip,et al. Management of epilepsy in children with autism , 2006 .
[10] A. Bailey,et al. Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. , 1996, Journal of child psychology and psychiatry, and allied disciplines.
[11] M. Gill,et al. Confirmation of association between autism and the mitochondrial aspartate/glutamate carrier SLC25A12 gene on chromosome 2q31. , 2005, The American journal of psychiatry.
[12] J. G. Bell,et al. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.
[13] Y. Tsujimoto,et al. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. , 1996, Cancer research.
[14] J. Marín-García,et al. Skeletal muscle mitochondrial defects in nonspecific neurologic disorders. , 1999, Pediatric neurology.
[15] T. Graeber,et al. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status , 1994, Molecular and cellular biology.
[16] B. H. Choi,et al. Oxidative stress in neurotoxic effects of methylmercury poisoning. , 1996, Neurotoxicology.
[17] O. Sheils,et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease , 2002, Molecular pathology : MP.
[18] M. Carrillo,et al. Age-related changes in antioxidant enzyme activities are region and organ, as well as sex, selective in the rat , 1992, Mechanisms of Ageing and Development.
[19] J. Shoffner,et al. Developmental Regression and Mitochondrial Dysfunction in a Child With Autism , 2006, Journal of child neurology.
[20] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[21] Eppright Td,et al. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. , 1996 .
[22] J. Sastre,et al. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. , 2003, Free radical biology & medicine.
[23] D. Figuera,et al. Mitochondrial respiration and oxidative phosphorylation during hypothermic hyperbaric hepatic preservation. , 1973, The Journal of surgical research.
[24] E. Leshinsky‐Silver,et al. Should Autistic Children Be Evaluated for Mitochondrial Disorders? , 2004, Journal of child neurology.
[25] P. Reddy. Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease , 2006, Journal of neurochemistry.
[26] M. Siepmann,et al. Influence of clinical factors, diet, and drugs on the human upper gastrointestinal glutathione system , 2002, Gut.
[27] D. Cantor,et al. The neurotoxic etiology of the autistic spectrum disorders: a replication study , 2000 .
[28] S. Morita,et al. Effects of pesticides on isolated rat hepatocytes, mitochondria, and microsomes II , 1993, Archives of environmental contamination and toxicology.
[29] I. O.,et al. Induction of apoptosis in human T-cells by methyl mercury: temporal relationship between mitochondrial dysfunction and loss of reductive reserve. , 1999, Toxicology and applied pharmacology.
[30] R. Busto,et al. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in wobbler mice , 2003, Neuroscience.
[31] W. Brown,et al. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. , 2004, Life sciences.
[32] W. McGinnis. Oxidative stress in autism. , 2004, Alternative therapies in health and medicine.
[33] L. Borjas,et al. [Clinical heterogeneity of the autistic syndrome: a study of 60 families]. , 1992, Investigacion clinica.
[34] N. Saunders,et al. Developmental neurotoxicity of industrial chemicals , 2007, The Lancet.
[35] S. Dimauro,et al. Mitochondrial DNA abnormalities and autistic spectrum disorders. , 2004, The Journal of pediatrics.
[36] A. Ascensão,et al. Acute and severe hypobaric hypoxia increases oxidative stress and impairs mitochondrial function in mouse skeletal muscle. , 2005, Journal of applied physiology.
[37] G. Marcaida,et al. Brain ATP Depletion Induced by Acute Ammonia Intoxication in Rats Is Mediated by Activation of the NMDA Receptor and Na+, K+‐ATPase , 1994, Journal of neurochemistry.
[38] Nathalie Boddaert,et al. Functional neuroimaging and childhood autism , 2001, Pediatric Radiology.
[39] I. Forsythe,et al. Presynaptic Mitochondrial Calcium Sequestration Influences Transmission at Mammalian Central Synapses , 2002, The Journal of Neuroscience.
[40] C. McMurray,et al. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases , 2007, Neuroscience.
[41] Dc Washington. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .
[42] J. Worth. Paraoxonase polymorphisms and organophosphates , 2002, The Lancet.
[43] S. Zoroglu,et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism , 2004, European Archives of Psychiatry and Clinical Neuroscience.
[44] J. Sastre,et al. Ginkgo biloba extract EGb 761 protects against mitochondrial aging in the brain and in the liver. , 2002, Cellular and molecular biology.
[45] I. Rapin,et al. Frequency of Gastrointestinal Symptoms in Children with Autistic Spectrum Disorders and Association with Family History of Autoimmune Disease , 2006, Journal of developmental and behavioral pediatrics : JDBP.
[46] Francis Boon,et al. Neurobiological effects of intraventricular propionic acid in rats: Possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders , 2007, Behavioural Brain Research.
[47] G. Moore,et al. Evidence of altered energy metabolism in autistic children , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[48] E Courchesne,et al. Autism Associated With the Mitochondrial DNA G8363A Transfer RNALys Mutation , 2000, Journal of child neurology.
[49] C. Barthélémy,et al. Plasma fatty acid levels in autistic children. , 2001, Prostaglandins, leukotrienes, and essential fatty acids.
[50] John H. Zhang,et al. Oxygen treatment restores energy status following experimental neonatal hypoxia-ischemia , 2007, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[51] F. Macciardi,et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene–environment interactions , 2005, Molecular Psychiatry.
[52] S. Fatemi,et al. Levels of Bcl-2 and P53 Are Altered in Superior Frontal and Cerebellar Cortices of Autistic Subjects , 2003, Cellular and Molecular Neurobiology.
[53] B. Ames,et al. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[54] Tonya Clark-Taylor,et al. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. , 2004, Medical hypotheses.
[55] T. Uema,et al. Abnormal regional cerebral blood flow in childhood autism. , 2000, Brain : a journal of neurology.
[56] Hidetoshi Nojiri,et al. Oxidative Stress Causes Heart Failure with Impaired Mitochondrial Respiration* , 2006, Journal of Biological Chemistry.
[57] C. Gillberg,et al. AUTISM IN THALIDOMIDE EMBRYOPATHY: A POPULATION STUDY , 1994, Developmental medicine and child neurology.
[58] K. Davis,et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. , 2004, The American journal of psychiatry.
[59] J. Lombard. Autism: a mitochondrial disorder? , 1998, Medical hypotheses.
[60] L. Croen,et al. Autism Spectrum Disorders in Relation to Distribution of Hazardous Air Pollutants in the San Francisco Bay Area , 2006, Environmental health perspectives.
[61] J. Blass,et al. Autism and lactic acidosis , 1985, Journal of autism and developmental disorders.
[62] D. Cantor,et al. Autism: Xenobiotic Influences , 1998, Toxicology and industrial health.
[63] L. Martin. Mitochondriopathy in Parkinson Disease and Amyotrophic Lateral Sclerosis , 2006, Journal of neuropathology and experimental neurology.
[64] H. Forman,et al. Glutathione in Defense and Signaling , 2002 .
[65] T. Eppright,et al. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. , 1996, Missouri medicine.
[66] S. Fatemi,et al. Altered levels of Bcl2 and p53 proteins in parietal cortex reflect deranged apoptotic regulation in autism , 2001, Synapse.
[67] M. Zeviani,et al. Neurological presentations of mitochondrial diseases , 1996, Journal of Inherited Metabolic Disease.
[68] P. Rodier,et al. Early environmental factors in autism , 1998 .
[69] G. Deuschl,et al. Involvement of the mitochondrial ATP-sensitive potassium channel in the neuroprotective effect of hyperbaric oxygenation after cerebral ischemia , 2006, Brain Research Bulletin.
[70] G. Baird,et al. A screening instrument for autism at 18 months of age: a 6-year follow-up study. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.
[71] B Chance,et al. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. , 1973, The Biochemical journal.
[72] David W Gaylor,et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.
[73] J. Schneider,et al. Autism and Autistic Symptoms Associated with Childhood Lead Poisoning , 2005 .
[74] Zachary Stein,et al. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. , 2006, Health & place.
[75] S. Morita,et al. Effects of pesticides on isolated rat hepatocytes, mitochondria, and microsomes , 1995, Archives of environmental contamination and toxicology.
[76] G. Oliveira,et al. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. , 2005, Developmental medicine and child neurology.
[77] R Day,et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. , 2001, The Journal of pediatrics.
[78] D. Rossignol,et al. Hyperbaric oxygen therapy may improve symptoms in autistic children. , 2006, Medical hypotheses.
[79] S. Dimauro,et al. Infantile encephalopathy associated with the MELAS A3243G mutation. , 1999, The Journal of pediatrics.
[80] A. Parrish,et al. Metal-induced apoptosis: mechanisms. , 2003, Mutation research.
[81] H. Forman,et al. Glutathione in defense and signaling: lessons from a small thiol. , 2002, Annals of the New York Academy of Sciences.
[82] V. Procaccio,et al. Estrogen Increases Mitochondrial Efficiency and Reduces Oxidative Stress in Cerebral Blood Vessels , 2005, Molecular Pharmacology.
[83] T. Matsuishi,et al. Possible Association Between Congenital Cytomegalovirus Infection and Autistic Disorder , 2003, Journal of autism and developmental disorders.
[84] Gaylan L Rockswold,et al. Effects of hyperbaric oxygen therapy on cerebral oxygenation and mitochondrial function following moderate lateral fluid-percussion injury in rats. , 2004, Journal of neurosurgery.
[85] S. Kuroda,et al. Mitochondrial encephalomyopathy (MELAS): Pathological study and successful therapy with coenzyme Q10 and idebenone , 1989, Journal of the Neurological Sciences.
[86] P. Filipek,et al. Relative Carnitine Deficiency in Autism , 2004, Journal of autism and developmental disorders.
[87] S. Dimauro,et al. Mitochondrial encephalomyopathy with coenzyme Q10 deficiency , 1997, Neurology.
[88] J. Infante,et al. Secondary carnitine deficiency and impaired docosahexaenoic (22:6n‐3) acid synthesis: a common denominator in the pathophysiology of diseases of oxidative phosphorylation and β‐oxidation , 2000, FEBS letters.
[89] Stepan Melnyk,et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[90] Janet K. Kern,et al. Evidence of Toxicity, Oxidative Stress, and Neuronal Insult in Autism , 2006, Journal of toxicology and environmental health. Part B, Critical reviews.
[91] P. Decouflé,et al. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. , 2001, Pediatrics.
[92] O. Yorbik,et al. Investigation of antioxidant enzymes in children with autistic disorder. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.
[93] J. Spollen,et al. A preliminary trial of ascorbic acid as supplemental therapy for autism , 1993, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[94] I. Görker,et al. Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl. , 2005, Journal of Psychiatry & Neuroscience.
[95] William J Walsh,et al. Altered vascular phenotype in autism: correlation with oxidative stress. , 2006, Archives of neurology.
[96] Jenifer Juranek,et al. Mitochondrial dysfunction in autistic patients with 15q inverted duplication , 2003, Annals of neurology.
[97] T. Sick,et al. Antioxidants, mitochondrial hyperoxidation and electrical recovery after anoxia in hippocampal slices , 1997, Brain Research.
[98] N. Chu,et al. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. , 1997, European neurology.
[99] D. Rossignol. Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism. , 2007, Medical hypotheses.
[100] E. Eck,et al. Serum serotonin, lactate and pyruvate levels in infantile autistic children. , 1994, Clinica chimica acta; international journal of clinical chemistry.
[101] Todd B. Sherer,et al. An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage , 2002, The Journal of Neuroscience.
[102] K. Davies,et al. Mitochondrial free radical generation, oxidative stress, and aging. , 2000, Free radical biology & medicine.
[103] Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000. , 2007, Morbidity and mortality weekly report. Surveillance summaries.
[104] J. Marín-García,et al. Mitochondrial Dysfunction in Patients With Hypotonia, Epilepsy, Autism, and Developmental Delay: HEADD Syndrome , 2002, Journal of child neurology.
[105] M. Carraway,et al. Oxygen-induced mitochondrial biogenesis in the rat hippocampus , 2006, Neuroscience.
[106] S. Ohta,et al. Dysfunction of mitochondria and oxidative stress in the pathogenesis of Alzheimer's disease: on defects in the cytochrome c oxidase complex and aldehyde detoxification. , 2006, Journal of Alzheimer's disease : JAD.
[107] N. Lane. Oxygen: The molecule that made the world , 2002 .
[108] J. Seagrave,et al. The Role of a Mitochondrial Pathway in the Induction of Apoptosis by Chemicals Extracted from Diesel Exhaust Particles1 , 2000, The Journal of Immunology.
[109] S. Browne,et al. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. , 1998, Proceedings of the National Academy of Sciences of the United States of America.